Rockbridge Investment Management’s Idexx Laboratories IDXX Stock Holding History

Rockbridge Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10	Closed	-$5.55K	–	351
2023 Q4	$5.55K	Buy	+10	New	+$4.7K	﹤0.01%	462
2022 Q3	–	Sell	-10	Closed	-$3.51K	–	325
2022 Q2	$3.51K	Sell	10 -72	-88%	-$29.4K	﹤0.01%	496
2022 Q1	$45.4K	Hold	82	–	–	0.01%	308
2021 Q4	$54K	Hold	82	–	–	0.01%	333
2021 Q3	$51K	Hold	82	–	–	0.01%	314
2021 Q2	$52K	Hold	82	–	–	0.01%	306
2021 Q1	$40K	Buy	82 +10	+14%	+$5.01K	0.01%	320
2020 Q4	$36K	Hold	72	–	–	0.01%	329
2020 Q3	$28K	Hold	72	–	–	0.01%	331
2020 Q2	$24K	Buy	+72	New	+$20.8K	0.01%	319

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockbridge Investment Management's IDXX Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 10 shares — an estimated $5.55K sold.

Rockbridge Investment Management first reported a position in IDXX in Q2 2020 and held it in 10 quarters. The position peaked at $54K in Q4 2021. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Rockbridge Investment Management reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 10 Idexx Laboratories shares in Q1 2024, an estimated $5.55K.
Rockbridge Investment Management first reported a position in Idexx Laboratories in Q2 2020 and held it in 10 quarters.
Rockbridge Investment Management's Idexx Laboratories position peaked at $54K in Q4 2021.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.